Pharmacological management of adverse events during treatment of chronic viral hepatitis in three Ivorian university hospitals .

Objective: This work aims to evaluate the therapeutic survey of adverse events during antiviral treatment of hepatitis in the three major University Hospitals in Abidjan.

Materials And Methods: A retrospective cross-sectional descriptive study of 203 patients from August 1, 2015, to July 31, 2018, enumerated adverse events during antiviral treatments, drugs used for their management, and their clinical or biological impact.

Results: The following was seen: hematological disorders during treatment with pegylated interferon α-2a (88.